Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs03398790

Ligand	Ligand name	Chain	PDB	Tanimoto
9OH	(TRANS-12,13-EPOXY)-9-HYDROXY-10(E)-OCTADECENOIC ACID	A	1IK3	0.75
SIM	SIMVASTATIN	A,B,C,D	1HW9	0.73
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A	2ZB4	0.87
5OP	(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID	A,B	1V3V	0.87
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.7
11O	(TRANS-12,13-EPOXY)-11-HYDROXY-9(Z)-OCTADECENOIC ACID	A	1IK3	0.73
HO2	(9E,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A	3DBM	0.76
T25	(9Z)-11-[(2R,3S)-3-pentyloxiran-2-yl]undec-9-enoic acid	A,B	2RCL	0.71
T25	(9Z)-11-[(2R,3S)-3-pentyloxiran-2-yl]undec-9-enoic acid	A,B	3DSK	0.71
OLC	(2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate	A	3D4S	0.7
13S	13(S)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID	A	1IK3	0.74
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.71
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.71
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.7
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.7
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.7
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,B,E	1R8Q	0.73
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A	1RE0	0.73
AFB	1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE	A,E	1S9D	0.73
ASY	(12E)-10-oxooctadec-12-enoic acid	A,B	3CEE	0.7
PGX	7-[6-(3-HYDROPEROXY-OCT-1-ENYL)-2,3-DIOXA-BICYCLO[2.2.1]HEPT-5-YL]-HEPT-5-ENOIC ACID	A,B,C,D	1DDX	0.79
0MA	maslinic acid	A	2QN2	0.71
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.72
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	3DSJ	0.76
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2RCH	0.76
243	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	A,B	2VST	0.76
164	2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID	A	1R6W	0.76
CDZ	3,5-dihydroxy-4,6,6-tris(3-methylbut-2-en-1-yl)-2-(2-methylpropanoyl)cyclohexa-2,4-dien-1-one	A	2QNV	0.71
13R	13(R)-HYDROPEROXY-9(Z),11(E)-OCTADECADIENOIC ACID	A	1IK3	0.74
1NB	2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL	P	1BRU	0.71
T24	(9Z,11E,13S,15Z)-13-hydroxyoctadeca-9,11,15-trienoic acid	A,B	3DSI	0.76
13T	13-DEOXYTEDANOLIDE	0,1,3,9,A,B,C,H,J,K,L,M,N,O,Q,R,S,T,U,Y,Z	2OTJ	0.7
9HO	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid	A,B	2VSR	0.76
PG2	PROSTAGLANDIN D2	A,B	1RY0	0.95
OPD	9R,13R-12-OXOPHYTODIENOIC ACID	A,B	1ICQ	0.73
803	LOVASTATIN	A,B	1CQP	0.71
RCL	RICINOLEIC ACID	A	2CM4	0.76
RCL	RICINOLEIC ACID	A	2CM9	0.76
RCL	RICINOLEIC ACID	A	1FK7	0.76
E4H	(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE	A,B	2HFK	0.77
LVA	(3R,5R)-7-((1R,2R,6S,8R,8AS)-2,6-DIMETHYL-8-{[(2R)-2-METHYLBUTANOYL]OXY}-1,2,6,7,8,8A-HEXAHYDRONAPHTHALEN-1-YL)-3,5-DIHYDROXYHEPTANOIC ACID	A,B	1T02	0.71
114	COMPACTIN	A,B,C,D	1HW8	0.71
6OB	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	A,B	2VV4	0.81
E2P	PROSTAGLANDIN B2	A	1CZ2	0.73
6OC	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	A,B	2VV4	0.82
8PG	(8S,12S)-15S-HYDROXY-9-OXOPROSTA-10Z,13E-DIEN-1-OIC ACID	A,B	2G5W	0.85